Engagement of programmed death protein-1 (PD1), expressed on activated T lymphocytes [67], with their ligands PD-L1 or PD-L2, inhibits T cell activation [68,69] and results in failure of T cells to respond to tumours [70]. The gene discussed is PDCD1LG2; the disease is neoplasm.